Factores sociosanitarios y prevalencia del síndrome del intestino irritable según los criterios diagnósticos de Roma III en una población general de Colombia

Álvarez, David Felipe Gómez; Vargas, Julián Guillermo Morales; Medina, Luis Mariano Aurelio Rojas; Oviedo, Sandra; Camacho, Paul Anthony; Jaimes, Germán Eduardo Rueda

doi:10.1016/j.gastrohep.2009.01.177

Cited by 25 publications

(14 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is consistent with our prior studies in Mexico [8, 9]. The higher frequency of IBS-C compared to IBS-D seems to be a common finding in Latin American studies [26, 30], except for Argentina [31] where IBS-D is the predominant subtype. This latter discordance might relate to genetic and environmental influences in populations such as Argentina with a greater European influence.…”

Section: Discussionsupporting

confidence: 92%

“…In fact, a recent joint conference of the Rome Foundation and the World Gastroenterology Organization (WGO) about the global perspective of IBS concluded that it was necessary to conduct population-based studies to estimate the frequency of this functional bowel disorder worldwide [24]. The 16.0% frequency of IBS in the current study is concordant with a parallel study that was conducted in Central America (Nicaragua) using Rome II criteria that reported a 13.2% prevalence [25] and with the 19.9% reported in a population-based study from South America (Colombia), using Rome III criteria [26]. In contrast, our prevalence is eight times higher than the one reported in a multinational study in Europe using Rome II criteria [1].…”

Section: Discussionsupporting

confidence: 81%

See 1 more Smart Citation

The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study

López‐Colombo

Morgan

Bravo-González

et al. 2012

Gastroenterology Research and Practice

View full text Add to dashboard Cite

Aims. The frequency of functional gastrointestinal disorders (FGIDs) in the general population of Mexico is unknown. Methods. To determine the prevalence of FGIDs, associated depression, and health care utilization, a population-based sampling strategy was used to select 500 households in the State of Tlaxcala, in central Mexico. Household interviews were conducted by two trained physicians using the Rome II Modular Questionnaire, a health-care and medication used questionnaire and the CES-D depression scale. Results. The most common FGIDs were IBS: 16.0% (95% CI: 12.9–19.5); functional bloating: 10.8% (8.2–13.9); unspecified functional bowel disorder: 10.6% (8.0–13.6); and functional constipation (FC): 7.4% (5.3–10.1). Uninvestigated heartburn was common: 19.6% (16.2–23.4). All FGIDs were equally prevalent among both genders, except for IBS (P = 0.001), IBS-C (P < 0.001), IBS-A/M (P = 0.049), and FC (P = 0.039) which were more frequent in women. Subjects with FGIDs reported higher frequencies of medical visits: 34.6 versus 16.8%; use of medications: 40.7 versus 21.6%; (both P < 0.001); and reported depression: 26.7 versus 6.7%, (P < 0.001). Conclusion. In this first population-based study of FGIDs in Mexico, heartburn, IBS, functional distension, and FC were common. Only IBS, IBS-C, IBS-A/M, and FC were more frequent in women. Finally, FGIDs in Mexico had an increased burden of health care utilization and depression.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionsupporting

confidence: 81%

The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study

López‐Colombo

Morgan

Bravo-González

et al. 2012

Gastroenterology Research and Practice

View full text Add to dashboard Cite

show abstract

“…Although previous population-based studies from Korea showed a similar prevalence of IBS in both sexes,4-6 many studies from Western populations have shown female predominance 2,9,10. Current smoking and frequent alcohol consumption had a strong positive association with IBS in univariate analysis; however, in multivariate analysis, IBS was weakly associated with current smoking and not associated with frequent alcohol consumption.…”

Section: Discussionmentioning

confidence: 63%

Prevalence and Risk Factors of Irritable Bowel Syndrome in Healthy Screenee Undergoing Colonoscopy and Laboratory Tests

Nam¹,

Kim²,

Ryu³

et al. 2010

J Neurogastroenterol Motil

View full text Add to dashboard Cite

IntroductionThe prevalence of irritable bowel syndrome (IBS) after excluding organic disease has not been reported in Korea.MethodsOf 5,605 participants in a health screening program, inclusion criteria were persons who underwent colonoscopy and completed questionnaires. Exclusion criteria were persons diagnosed with colon cancer, inflammatory bowel disease, previous colectomy, and abnormal results of thyroid function tests. IBS was defined by Rome III criteria. Physical and psychological stress was evaluated with visual analogue scales, ranging from 0 to 10. Risk factors for IBS were estimated with odds ratios (OR) and 95% confidence intervals (CI) using logistic regression analysis.ResultsThe prevalence of IBS was 8.2% (5,605) in the total population and 9.1% (393/4,296) in the final study sample. IBS had a positive association with female sex (adjusted OR, 1.33; 95% CI, 1.00-1.79; p = 0.05) and current smoking (adjusted OR, 1.31; 95% CI, 1.00-1.71; p = 0.05). The prevalence of IBS increased with increased psychological stress (adjusted p for trend = 0.005) and decreased with increasing age (adjusted p for trend <0.001), with adjusted OR of 0.95 (95% CI, 0.68-1.33) for age of 40.0 to 49.9 years; 0.79 (95% CI, 0.54-1.15) for age of 50.0 to 59.9 years; and 0.51 (95% CI, 0.30-0.86) for age of 60 years or more, compared with age less than 40 years. Drinking status, body mass index, hypertension, diabetes, and use of sedatives had no association with IBS.ConclusionsThe prevalence of IBS increased with decreasing age and increasing psychological stress, and was positively associated with female sex and current smoking.

show abstract

“…Por una parte, el síndrome de intestino irritable (SII) es considerado un síndrome gastrointestinal funcional que se ha asociado con hipersensibilidad visceral, alteración de la motilidad del TGI, enfermedad postinfecciosa y comorbilidades psiquiátricas (3,4). Se le ha estimado una prevalencia mundial de 10%-20% con predominio femenino en proporción 3:2.…”

unclassified

“…Se le ha estimado una prevalencia mundial de 10%-20% con predominio femenino en proporción 3:2. En Colombia presenta una prevalencia de 20% en población adulta, con predominio de la variante mixta (diarrea y estreñimiento), asociado con un alto número de incapacidades médicas y restricciones en la actividad física (4,5).…”

unclassified

Uso de probióticos en síndrome de intestino irritable y enfermedad inflamatoria intestinal: una revisión de la literatura

Gil-Tamayo

et al. 2017

Rev. Colomb. Gastroenterol.

View full text Add to dashboard Cite

Introducción: El síndrome de intestino irritable (SII) y la enfermedad inflamatoria intestinal (EII), son motivos de consulta frecuente. Usualmente su tratamiento se hace en primer nivel de atención, con ajuste de estilo de vida y cambios dietarios. Los tratamientos farmacológicos tienen eficacia limitada e importantes efectos secundarios, por lo que existe un interés creciente en terapias diferentes como el uso de probióticos.Métodos: Se realizó una revisión de la literatura en las bases de datos Medline y Embase buscando estudios que asociaran suplementos nutricionales, con SII o EII, haciendo énfasis en probióticos.Resultados: De un total de 1598 referencias, 43 cumplieron criterios finales de inclusión. El uso de probióticos en SII y EII sugiere ser una terapia que ayuda a mantener los periodos de remisión de enfermedad, mejorar la calidad de vida y atenuar el proceso fisiopatológico.Conclusiones: El uso de probióticos y prebióticos podría ser una alternativa de soporte nutricional en pacientes seleccionados.

show abstract

Factores sociosanitarios y prevalencia del síndrome del intestino irritable según los criterios diagnósticos de Roma III en una población general de Colombia

Cited by 25 publications

References 25 publications

The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study

The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study

Prevalence and Risk Factors of Irritable Bowel Syndrome in Healthy Screenee Undergoing Colonoscopy and Laboratory Tests

Uso de probióticos en síndrome de intestino irritable y enfermedad inflamatoria intestinal: una revisión de la literatura

Contact Info

Product

Resources

About